Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-059515

Director acquired 194 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anderson Kenneth Carl Director 2021-10-04 Grant or award +194 $44.99 $8,728 85,560 D
Loading xslF345X03/doc4.xml…